The estimated Net Worth of Beverly A Huss is at least $218 ezer dollars as of 22 May 2024. Ms. Huss owns over 4,300 units of Accuray Inc stock worth over $8,471 and over the last 7 years she sold ARAY stock worth over $0. In addition, she makes $209,999 as Independent Director at Accuray Inc.
Beverly has made over 1 trades of the Accuray Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently she bought 4,300 units of ARAY stock worth $29,498 on 22 May 2024.
The largest trade she's ever made was buying 4,300 units of Accuray Inc stock on 22 May 2024 worth over $29,498. On average, Beverly trades about 269 units every 0 days since 2018. As of 22 May 2024 she still owns at least 4,300 units of Accuray Inc stock.
You can see the complete history of Ms. Huss stock trades at the bottom of the page.
Beverly A. Huss is an Independent Director of the Company. Since September 2013, she has served as President and Chief Executive Officer of Qool Therapeutics, Inc. (“Qool”), formerly Thermocure, Inc., a development stage company focused on creating a novel non-invasive device for the preservation of tissue following a heart attack, stroke, traumatic brain injury and other medical conditions. Prior to joining Qool, Ms. Huss was President and Chief Executive Officer at Vibrynt, Inc., an early-stage medical device company, from January 2006 through March 2013. Prior to that, she held multiple senior level leadership positions at Guidant Corporation from 1986 to 2005, including, most recently as President, Endovascular Solutions, and prior to that Vice President of Global Marketing for Vascular Intervention. Ms. Huss began her career as a Metallurgical Engineer in 1982. Ms. Huss currently serves on the board of directors of Qool, Madorra, a privately-held medical device company developing solutions to improve quality of life after menopause, and Kalera Medical, a privately-held developer of devices designed to remove kidney stone fragments. Her prior public company board experience includes Artes Medical, Wright Medical Group and Dade Behring Holdings, Inc. Ms. Huss holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois.
As the Independent Director of Accuray Inc, the total compensation of Beverly Huss at Accuray Inc is $209,999. There are 12 executives at Accuray Inc getting paid more, with Ali Pervaiz having the highest compensation of $5,183,662.
Beverly Huss is 59, she's been the Independent Director of Accuray Inc since 2018. There are 6 older and 7 younger executives at Accuray Inc. The oldest executive at Accuray Inc is Elizabeth Davila, 75, who is the Independent Director.
Beverly's mailing address filed with the SEC is 1310, Chesapeake Terrace, Sunnyvale, Santa Clara County, California, 94089, United States.
Over the last 18 years, insiders at Accuray Inc have traded over $37,863,458 worth of Accuray Inc stock and bought 806,995 units worth $5,047,672 . The most active insiders traders include International Investment Ho..., Robert S Weiss és Euan Thomson. On average, Accuray Inc executives and independent directors trade stock every 24 days with the average trade being worth of $62,792. The most recent stock trade was executed by Ali Pervaiz on 4 September 2024, trading 8,404 units of ARAY stock currently worth $17,312.
accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.
Accuray Inc executives and other stock owners filed with the SEC include: